Strengthening Pharmaceutical Oversight: The Debate Over Mandatory CCTV Surveillance in Retail Pharmacies

The Union Health Ministry has proposed a significant regulatory shift by mandating CCTV surveillance in retail medical stores. This policy intervention is primarily aimed at curbing the rampant abuse and diversion of habit-forming drugs, specifically those categorized under Schedule X of the Drugs and Cosmetics Rules. By ensuring real-time monitoring and creating a digital audit trail, the government intends to enhance transparency in the pharmaceutical supply chain and prevent the unauthorized sale of controlled substances that contribute to substance abuse crises. However, the proposal has triggered a contentious debate between regulatory authorities and the pharmacy sector. Pharmacists and industry associations have raised valid concerns regarding the operational and financial burden of installing and maintaining surveillance infrastructure, particularly for small-scale, independent chemists. Furthermore, the move has sparked a broader discourse on the right to privacy. Critics argue that constant video monitoring of patients purchasing sensitive medication could lead to the stigmatization of individuals seeking treatment for mental health or addiction-related issues, potentially deterring them from accessing necessary healthcare services.